Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cancer Treatment-Induced Arrhythmia with TCAs

J Am Heart Assoc; ePub 2018 Oct 13; Nickel, et al

Compared with anthracyclines, treatment with novel targeted chemotherapeutic agents (TCAs) was associated with a significantly reduced risk of new-onset arrhythmia diagnosis during the first 6 months of treatment, according to a recent study. 5,026 patients were identified, of whom 2,951 (58.7%) received TCAs and 2,075 (41.3%) received anthracycline chemotherapy. Cancer treatment-induced arrhythmia (CTIA) was defined as any new arrhythmia diagnosis code within 6 months after treatment initiation. Researchers found:

  • In the overall cohort, 601 (12.0%) patients developed CTIA.
  • Patients with CTIA were significantly older and more likely to have hypertension, diabetes mellitus, congestive heart failure, coronary disease, and sleep apnea.
  • The incidence of CTIA at 6 months was significantly lower in the TCA group (9.3% vs 15.8%).
  • In a multivariate analysis, treatment with TCAs compared with anthracycline chemotherapy was associated with a significantly lower risk of CTIA (HR, 0.60).

Citation:

Nickel AC, Patel A, Saba NF, Leon AR, El-Chami MF, Merchant FM. Incidence of cancer treatment-induced arrhythmia associated with novel targeted chemotherapeutic agents. [Published online ahead of print October 13, 2018]. J Am Heart Assoc. doi:10.1161/JAHA.118.010101.

This Week's Must Reads

PAD tied to higher prevalence of LV diastolic dysfunction, Yanaka K et al. J Cardiol. 2019 Feb 18. doi: 10.1016/j.jjcc.2019.01.011

Diabetic kidney disease, retinopathy associated with PAD in patients with foot ulcers, Megallaa MH et al. Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1287-92.

LDL-C & CV Outcomes in Hypertensive Patients, Intl J Cardiol; ePub 2019 Jan 15; Nguyen, et al

High Rates of PCSK9 Inhibitor Access & Initiation, J Clin Lipidol; ePub 2019 Jan 14; Reynolds, et al

Must Reads in Arrhythmias & EP

Sudden Cardiac Death Risk in the US, Am J Cardiol; ePub 2019 Jan 24; Olson, et al

Thyroid Function Genetic Predictors and AF, JAMA Cardiol; ePub 2019 Jan 23; Salem, et al

Depressive Symptoms and Risk of Incident AF, J Am Heart Assoc; ePub 2018 Dec 19; Garg, et al

Anticoagulation in Patients with AF and HF, Clin Cardiol; ePub 2018 Dec 23; Contreras, et al

Catheter Ablation for AF in Adults with CHD, Heart Rhythm; ePub 2018 Dec 26; Liang, et al